Intervju med vd för AcuCorts i samband med nyemission

16 September 2019 - 11:32
AcuCort gör en nyemission på 41 miljoner kronor. I samband med detta svarar vd Mats Lindfors på frågor om verksamheten....
Spotlight (Sweden)
AcuCort AB
AcuCort operates within medical technology. The company develops fast-dissolving oral films with specific chemical substances that are used for the treatment of acute allergic reactions, as well as for nausea and vomiting during chemotherapy treatments. The products can be used by both children and adults. The main part of the business is within the Nordic markets. AcuCort was founded in 2006 and...
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date